23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Lilly’s obesity ads on the underground cleared by watchdog

Eli Lilly’s advertising campaign about obesity did not breach industry rules on advertising aimed at the general public, according to a ruling by the Swedish pharmaceutical industry’s Information Examination Board (IGN).
Advertisement

This autumn, passengers on the Stockholm underground have been greeted not only by the usual adverts for radio stations, the latest museum exhibitions and cinnamon buns from Pressbyrån, but also by obesity awareness ads from pharmaceutical company Eli Lilly.

“No one would tell someone with an allergy that it was self-inflicted,” the campaign’s message read, adding that obesity is a disease and should be treated as such.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.062|